Why the study?
Does intravenous propofol compared to midazolam alter heart rate variability and hemodynamics in dental patients undergoing conscious sedation?
Does intravenous propofol compared to midazolam alter heart rate variability and hemodynamics in dental patients undergoing conscious sedation?
Propofol enhances parasympathetic dominance while midazolam enhances sympathetic dominance during conscious sedation, highlighting differential autonomic effects relevant for patients at risk of cardiovascular complications.
Answers are grounded in this paper and cite their sources.
Supports preferring propofol over midazolam in patients at sympathetic overdrive risk; extends RCT data on sedation-specific autonomic modulation.
In Brief Heart rate (HR) and arterial blood pressure (BP) changes have been reported during conscious sedation with propofol and midazolam. One potential mechanism to explain these changes is that propofol and midazolam affect HR and BP via changes in the cardiac autonomic nervous system. Two specific hypotheses were tested by HR variability analysis: 1) propofol induces predominance of parasympathetic activity, leading to decreased HR and BP, and 2) midazolam induces predominance of sympathetic activity, leading to increased HR and decreased BP. Thirty dental patients were included in a prospective, randomized study. HR, BP, low frequency (LF), high frequency (HF), and entropy were monitored during the awake, sedation, and recovery periods and depth of sedation was assessed using the Observer’s Assessment of Alertness/Sedation score. Propofol induced a significant decrease in total power (503 ± 209 ms2/Hz versus 162 ± 92 ms2/Hz) and LF/HF ratio (2.5 ± 1.2 versus 1.0 ± 0.4), despite the absence of any change in HR during the sedation period compared with baseline. Midazolam decreased normalized HF (34 ± 10% versus 10 ± 4%) but did not significantly change LF/HF ratio (2.3 ± 1.1 versus 2.2 ± 1.4) and increased HR in the sedation period. Compared with baseline, propofol was associated with a significant increase in normalized HF in the recovery period (34 ± 11% versus 44 ± 12%) and a significant decrease in HR, whereas midazolam was associated with an increase in LF/HF ratio (2.3 ± 1.1 versus 3.7 ± 1.8) with no change in HR. These results indicated a dominant parasympathetic effect of propofol and a dominant sympathetic effect of midazolam in both periods. These results should be considered during conscious sedation, especially in patients at risk of cardiovascular complications. IMPLICATIONS: Propofol enhances the dominance of parasympathetic activity, which is associated with decreased heart rate (HR) and arterial blood pressure (BP). Midazolam enhances the dominance of sympathetic activity, which is associated with increased HR and decreased BP. These differences in effects on cardiac autonomic nervous system activity during conscious sedation are important in patients at risk of cardiovascular complications.
No takes yet. Share an insight, caveat, or question.
Win et al. (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: